A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway.
致病性烟雾相关的中性粒细胞外泌体途径。
基本信息
- 批准号:10614014
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AlveolarAntibodiesBindingBiological MarkersBiologyCellsCharacteristicsChronic Obstructive Pulmonary DiseaseCollagen Type IComplexCoughingDevelopmentDiseaseDisease ProgressionDisease modelDissociationEarly identificationExcisionExtracellular MatrixExtracellular Matrix ProteinsFutureGenerationsGoalsGrantHumanIn VitroIndividualInflammationInflammatoryIntegrinsLeukocyte ElastaseLinkLiquid substanceLungLysineMacrophage-1 AntigenMeasuresMembraneMethodsModelingMolecularMusPaperPathogenesisPathogenicityPathway interactionsPatientsPeptide HydrolasesPhasePhenotypePopulationPredispositionProductionProtaminesProtease InhibitorProteoglycanPulmonary EmphysemaRIPK3 geneResistanceRespiratory FailureRisk FactorsRoleSamplingSerine ProteaseSerumSeverity of illnessShortness of BreathSiteSmokeSmokerSmokingSputumSurfaceTherapeuticTrypsinWorkairway obstructionalpha 1-Antitrypsinalveolar destructionchronic inflammatory diseasecohortdisease phenotypeexosomeexposure to cigarette smokehigh risk populationimprovedin vivoinhibitormouse modelnanovesicleneutrophilnever smokernon-smokingpatient stratificationrisk stratificationsmoking-related lung diseasetherapeutic targetvesicular release
项目摘要
Project Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease believed to be driven
by protease-antiprotease imbalance. The mechanisms leading to this imbalance have yet to be fully
understood. Recent work has suggested that exosomes (small nanovesicles released by cells) from
activated neutrophils (PMNs) are coated in neutrophil elastase (NE) from degranulated PMNs and this
exosome associated NE renders it protected from its native antiprotease, alpha-1-antitrypsin (α1AT).
This resistance to α1AT makes exosome associated NE several log-fold more potent in causing a COPD
disease-like phenotype in mouse models than free NE in solution. These PMN exosomes can bind to
type I collagen and degrade structural extracellular matrix (ECM) proteins. Of bigger significance, these
PMN derived NE+ exosomes can cause alveolar destruction in a mouse model and these NE+ exosomes
can be found in the BALF of COPD patients, but not healthy never smoker controls, indicating an
important role for exosome associated NE in COPD disease progression. This grant will identify the
mechanism of NE association to the surface of PMN exosomes as well as focusing on molecules to
disrupt this association, rendering the NE susceptible to α1AT inactivation. Furthermore, this grant will
develop a smoking mouse model of NE+ PMN exosome production and disease transfer to naïve mice,
effectively creating a mouse-mouse transfer model of disease. Additionally, this grant will correlate the
presence of PMN NE+ exosomes in COPD patient BALF with other significant parameters of COPD
severity. Moreover, PMN derived NE+ exosomes from other, less invasive patient fluid samples, serum
and sputum, will be quantified and their ability to transfer disease to mouse model of COPD will be
compared to those from patient BALF. Additionally, substances studied that can dissociate NE from the
exosome surface can be developed into potential therapeutic targets.
项目摘要
慢性阻塞性肺疾病(COPD)是一种慢性炎症性疾病,据信由
由蛋白酶-抗蛋白酶失衡所致。导致这种不平衡的机制尚未完全形成。
明白了。最近的研究表明,外小体(由细胞释放的小纳米囊泡)来自
激活的中性粒细胞(PMN)包被来自脱颗粒的PMN的中性粒细胞弹性蛋白酶(NE),这
外切体相关的NE使其免受其天然抗蛋白酶-α-1-抗胰蛋白酶(α1AT)的保护。
这种对α1AT的抵抗力使外切体相关NE在导致慢性阻塞性肺疾病方面的效力提高了几倍
小鼠模型中的疾病表型比溶液中游离NE的表型要好。这些PMN外切体可以结合到
I型胶原和降解结构性细胞外基质(ECM)蛋白。更重要的是,这些
中性粒细胞来源的NE+外切体可引起小鼠模型的肺泡破坏,这些NE+外切体
在COPD患者的BALF中可以发现,但不是健康的从不吸烟的对照组,这表明
外切体相关NE在COPD疾病进展中的重要作用。这笔赠款将确定
去甲肾上腺素与中性粒细胞外切体表面结合的机制及对分子作用的研究
破坏这种联系,使NE容易受到α1AT失活的影响。此外,这笔赠款将
建立NE+PMN外切体产生吸烟小鼠模型并将疾病转移给幼稚小鼠,
有效地创建了一种老鼠-老鼠传播疾病的模型。此外,这笔赠款将与
COPD患者BALF中中性粒细胞NE+外切体的存在与COPD的其他重要指标
严肃性。此外,PMN来源于其他侵入性较小的患者体液样本、血清中的NE+外切体
和痰,将被量化,它们将疾病传播到COPD小鼠模型的能力将是
与患者的BALF相比。此外,所研究的物质可以将NE从
外切体表面可以发展成为潜在的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristopher R. Genschmer其他文献
Kristopher R. Genschmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristopher R. Genschmer', 18)}}的其他基金
A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway.
致病性烟雾相关的中性粒细胞外泌体途径。
- 批准号:
10416774 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:
相似海外基金
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10454419 - 财政年份:2021
- 资助金额:
$ 37.13万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10672258 - 财政年份:2021
- 资助金额:
$ 37.13万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10293635 - 财政年份:2021
- 资助金额:
$ 37.13万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 37.13万 - 项目类别:
Studentship
Covalent binding Antibodies as a Chemical Tool to Probe Immune Molecular Recognition
共价结合抗体作为探测免疫分子识别的化学工具
- 批准号:
565778-2021 - 财政年份:2021
- 资助金额:
$ 37.13万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Establishment of a novel serum diagnosis method for flaviviruses based on binding profiles of anti-flavivirus antibodies
基于抗黄病毒抗体结合谱建立黄病毒新型血清诊断方法
- 批准号:
20J22269 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of Antigen Glycosylation in Mucin Binding by Monoclonal Antibodies
抗原糖基化在单克隆抗体粘蛋白结合中的作用
- 批准号:
10045898 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Do anti-DNA antibodies play a role in the pathogenesis of systemic lupus erythematosus by binding/entering live cells?
抗 DNA 抗体是否通过结合/进入活细胞在系统性红斑狼疮的发病机制中发挥作用?
- 批准号:
16K08929 - 财政年份:2016
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
N-Terminally fluorescent-labeled antibodies that show fluorescence change upon antigen-binding
N 末端荧光标记抗体,在抗原结合时显示荧光变化
- 批准号:
15K13739 - 财政年份:2015
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
(i) Identification of single-molecule protein complexes involved in cellular transport of prosthetic groups (Moco and heme) (ii) Generation of monoclonal antibodies directed against protein motifs involved in binding prosthetic groups
(i) 鉴定参与假体基团(Moco 和血红素)细胞运输的单分子蛋白复合物 (ii) 生成针对参与结合假体基团的蛋白基序的单克隆抗体
- 批准号:
226653713 - 财政年份:2012
- 资助金额:
$ 37.13万 - 项目类别:
Research Units